Cargando…

Osteonecrosis in Adults With Acute Lymphoblastic Leukemia: An Unmet Clinical Need

Osteonecrosis is a serious complication of antileukemic therapy associated with severe pain and reduced mobility, ultimately leading to joint destruction and significant long-term morbidity. The 5-year cumulative incidence of osteonecrosis ranges from 11% to 20% in adolescents and young adults to 3%...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuhlen, Michaela, Kunstreich, Marina, Gökbuget, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951118/ https://www.ncbi.nlm.nih.gov/pubmed/33718802 http://dx.doi.org/10.1097/HS9.0000000000000544

Ejemplares similares

FAT1 expression and mutations in adult acute lymphoblastic leukemia
por: Neumann, M, et al.
Publicado: (2014)

Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods
por: Kotrová, Michaela, et al.
Publicado: (2022)

Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab
por: Kantarjian, Hagop M., et al.
Publicado: (2023)

Targeting Menin and CD47 to Address Unmet Needs in Acute Myeloid Leukemia
por: Matthews, Andrew H., et al.
Publicado: (2022)

Recent perspectives on the association between osteonecrosis and bone mineral density decline in childhood acute lymphoblastic leukemia
por: van Atteveld, Jenneke E, et al.
Publicado: (2021)

Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden
por: DeAngelo, Daniel J., et al.
Publicado: (2020)

General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia
por: Gökbuget, Nicola, et al.
Publicado: (2023)

Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
por: v. Stackelberg, Arend, et al.
Publicado: (2023)

Acute lymphoblastic leukemia in adults
por: Ribera, Josep-Maria
Publicado: (2011)

The Microbiome in Childhood Acute Lymphoblastic Leukemia
por: Oldenburg, Marina, et al.
Publicado: (2021)

Clinical use of blinatumomab for B-cell acute lymphoblastic leukemia in adults
por: Lee, Kum Ja, et al.
Publicado: (2016)

Unmet needs of bipolar disorder patients
por: Hajda, Miroslav, et al.
Publicado: (2016)

Long‐term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab
por: Topp, Max S., et al.
Publicado: (2020)

Effect of post-consolidation regimen on symptomatic osteonecrosis in three DCOG acute lymphoblastic leukemia protocols
por: van Atteveld, Jenneke E., et al.
Publicado: (2021)

Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL)
por: Padhye, Bhavna, et al.
Publicado: (2016)

Osteonecrosis in Korean Paediatric and Young Adults with Acute Lymphoblastic Leukaemia or Lymphoblastic Lymphoma: A Nationwide Epidemiological Study
por: Hahn, Seung Min, et al.
Publicado: (2022)

Are clinical pharmacology studies still needed in childhood acute lymphoblastic leukemia?
por: Conter, Valentino, et al.
Publicado: (2021)

Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia
por: Chitadze, Guranda, et al.
Publicado: (2023)

Emerging Pharmacotherapies for Adult Patients with Acute Lymphoblastic Leukemia
por: Lee, Lydia, et al.
Publicado: (2012)

Unmet Cardiac Clinical Needs in Adult Mucopolysaccharidoses
por: Stepien, Karolina M., et al.
Publicado: (2022)

Invasive candidiasis: current clinical challenges and unmet needs in adult populations
por: Soriano, Alex, et al.
Publicado: (2023)

Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia
por: Kobitzsch, Benjamin, et al.
Publicado: (2017)

Dominant T-cell Receptor Delta Rearrangements in B-cell Precursor Acute Lymphoblastic Leukemia: Leukemic Markers or Physiological γδ T Repertoire?
por: Kelm, Miriam, et al.
Publicado: (2023)

Treatment of Adolescent and Young Adults with Acute Lymphoblastic Leukemia
por: Ribera, Josep-Maria, et al.
Publicado: (2014)

Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome–positive relapsed/refractory acute lymphoblastic leukemia
por: Stock, Wendy, et al.
Publicado: (2020)

Unmet needs in asthma
por: Gruffydd-Jones, Kevin
Publicado: (2019)

An unmet clinical need: roads to remyelination in MS
por: Göttle, Peter, et al.
Publicado: (2019)

Atopic Dermatitis: Clinical Aspects and Unmet Needs
por: Lobefaro, Fabio, et al.
Publicado: (2022)

Acute optic neuritis: Unmet clinical needs and model for new therapies
por: Galetta, Steven L., et al.
Publicado: (2015)

Molecular characterization of TCF3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment
por: Burmeister, Thomas, et al.
Publicado: (2023)

T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness
por: Bardelli, Valentina, et al.
Publicado: (2021)

The evolution of clinical trials for infant acute lymphoblastic leukemia
por: Kotecha, R S, et al.
Publicado: (2014)

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
por: Gökbuget, N, et al.
Publicado: (2016)

Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Adults
por: Saleh, Khalil, et al.
Publicado: (2022)

Changing Landscape in the Treatment of Adult Acute Lymphoblastic Leukemia (ALL)
por: Künz, Tina, et al.
Publicado: (2022)

Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia
por: Koprivnikar, Jamie, et al.
Publicado: (2017)

Blinatumomab as first salvage versus second or later salvage in adults with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia: Results of a pooled analysis
por: Topp, Max S., et al.
Publicado: (2021)

Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020)

Is there an unmet medical need for improved hearing restoration?
por: Wolf, Bettina Julia, et al.
Publicado: (2022)

Approach to the Adult Acute Lymphoblastic Leukemia Patient
por: Sas, Valentina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d8ajmjccfarlpjfo8f8f8hgadj